|
(Health-NewsWire.Net, July 22, 2021 ) According to research report the precision medicine market is projected to reach $2.0 billion by 2024 from $1.2 billion in 2019, at a CAGR of 11.5%.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=247980900
Factors such as the rising government funding in precision medicine initiatives, the entry of new players & VC funding, partnerships among pharmaceutical and software companies and growth in the number of cancer patients are driving the growth of the precision medicine software market.
Syapse, Inc. (US), 2bPrecise LLC (Israel), Human Longevity, Inc. (US), Translational Software, Inc. (US), Sunquest Information Systems Inc. (US), Gene42, Inc. (Canada), IBM Watson Group (US), LifeOmic Health, LLC (US), Foundation Medicine, Inc. (US), Fabric Genomics (US), SOPHiA GENETICS SA (Switzerland), PierianDx, Inc. (US), N-of-One, Inc. (US), NantHealth, Inc. (US), Tempus Labs, Inc. (US), Flatiron Health, Inc. (US) and Koninklijke Philips N.V. (Netherlands) are the key players in the precision medicine software market.
By application, the oncology segment dominated the precision medicine market in 2018
Based on applications, the precision medicine software market is segmented into oncology, pharmacogenomics, rare diseases, and other applications. The oncology segment accounted for the largest market share in 2018. The large share of this segment can be attributed to the growing prevalence of cancer, rising funding in cancer research, promising applications of precision medicine in oncology research, and increased investments by government organizations in precision medicine software.
By delivery mode, cloud-based systems are to register the highest CAGR during the forecast period
On the basis of delivery mode, the precision medicine market is segmented into on-premise and cloud-based systems. The cloud-based segment is expected to register the highest CAGR of the precision medicine market during the forecast period. Growth in this segment can be attributed to the comparatively lower capital expenses and operational costs incurred in this model, alongside its scalability, flexibility, and affordability. Cloud-based solutions help healthcare organizations share and integrate information from different locations, and these solutions are comparatively affordable to install and maintain than on-premise solutions, which contribute to the high growth and popularity of the cloud-based delivery model.
Request For Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=247980900
North America dominated the market in 2018
Geographically, the North American market accounted for the largest share of the precision medicine software in 2018. The large market share of North America in the precision medicine software market can be attributed to factors such as growing HCIT investments in the region, the presence of regulatory mandates supporting market growth in the US, and increasing digitalization and favorable funding initiatives by the Canadian government.
Critical questions the report answers:
> Where will all these developments take the industry in the mid to long term?
> What are the upcoming precision medicine software solutions?
> Which of the application segments will dominate the precision medicine software market in the future?
> Emerging countries have immense opportunities for the growth and adoption precision medicine software solutions. Will this scenario continue in the next five years?
> Where will all the advancements in precision medicine software offered by various companies take the industry in the mid to long term?
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
sales@marketsandmarkets.com
MarketsandMarkets™
Mr. Aashish Mehra
1-888-600-6441
raviraj.tak@marketsandmarkets.com
Source: EmailWire.Com 
|
